Phenotypic and genotypic analysis of Streptococcus pneumoniae diversity during the introduction of pneumococcal conjugate vaccines in the UK
Year: 2014
Type: dissertation
Study design: Observational Study
Abstract: Streptococcus pneumoniae is a major global pathogen capable of causing pneumonia and meningitis, particularly at the extremes of age.Pneumococcal conjugate vaccines (PCV) to protect against invasive pneumococcal disease were implemented from 2006 in the UK.Asymptomatic carriage occurs in approximately one third of children aged 4 years and under in the UK, whilst colonisation is known as a precursor to disease.Vaccination against a limited number of the >90 serotypes was hypothesised to result in serotype replacement in carriage which, would in turn affect disease epidemiology.This thesis set out to characterise carried pneumococci from children aged 4 years and under, collected each winter from the introduction of 7-valent PCV in 2006 through to winter 2010/11, which extended one year after the introduction of 13-valent PCV.This work sought to detect changes in serotypes and genotypes, using traditional phenotypic and genotypic techniques, as well as to further validate and utilise next generation sequencing for determining typing data, and characterisation of the gene diversity targeted by current and investigational vaccines.Whole genome sequence analysis allowed robust derivation of typing that contributed to epidemiological analysis.Carriage remained stable, as did the number of serotypes and sequence types (STs) observed each year.Vaccine serotypes (VT) significantly decreased with a concomitant increase in non-vaccine serotypes (NVT).Significant decreases for VT 6A, 6B, 19F and 23F and increases for NVT 21, 23B, 33F and 35F were observed.Significant changes in prevalence were also observed for genotypes associated with these serotypes.Novel sequence variation was observed in capsular defining genes and pneumolysin, which has potential to affect the efficacy of vaccines against these targets.Near complete serotype replacement occurred during the introduction of PCV7 and is likely to continue for PCV13.This resulted in a greater number of NVT pneumococci colonising individuals, which could result in disease cases.Others have consequently observed serotype replacement in disease in the UK.The future of control of pneumococcal disease through vaccination will therefore require a response to this replacement, through targeting the most prevalent replacing serotypes or broader pneumococcal vaccines taking into account the variation within potential targets.Clarke, Dr Jo Jefferies and Dr Saul Faust for giving me the opportunity to study towards this doctoral degree, helping me progress thus far and fot their support and encouragement.I would like to acknowledge staff at Public Health England microbiology services Southampton and the research nurses, BM/BMedSci students for their hard work in the collection and processing of isolates.I would like to give special thanks to the children and their parents for participation in the carriage study.I would like to thank the staff at the University of Birmingham"s centre for genomics for allowing me to gain valuable expertise
Author: Rebecca A. Gladstone
Institution: University of Southampton
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2289767542
